Deciphera Pharmaceuticals, Inc. (DCPH)
After hours:
- Business Wire
Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer
WALTHAM, Mass., June 16, 2022--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced the appointment of Kelley Dealhoy as Senior Vice President and Chief Business Officer. Ms. Dealhoy brings 20 years of life science leadership experience to the role, and her responsibilities will include developing and leading the Company’s business development efforts as well as supporting corporate strategy initiatives.
- Zacks
Deciphera (DCPH) Up More Than 30% in Past 3 Months: Here's Why
Deciphera's (DCPH) Qinlock, approved for treating advanced gastrointestinal stromal tumors, has seen strong uptake since its approval. The recent restructuring initiative is saving costs.
- Zacks
Deciphera Pharmaceuticals, Inc. (DCPH) Up 4.3% Since Last Earnings Report: Can It Continue?
Deciphera Pharmaceuticals, Inc. (DCPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
